1Sampliner RE.Practice Parameters Committee of the American College of Gastroenterology.Updated guidelines for the diagnosis,surveillance,and therapy of Barrett's esophagus.Am J Gastroenterol,2002,97:1888～1895.
2Jang TJ,Min SK,Bae JD,Jung KH,Lee JI,Kim JR,Ahn WS.Expression of cyclooxygenase 2,microsomal prostaglandin E synthase 1,and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux.Gut,2004,53:27～33.
3Konturek PC,Nikiforuk A,Kania J,Raithel M,Hahn EG,Muhldorfer S.Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus:a possible link to the inflammation and overexpression of COX-2,PPARgamma and growth factors.Dig Dis Sci,2004,49:1075～1083.
4Wilson KT,Fu S,Ramanujam KS,Meltzer SJ.Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.Cancer Res,1998,58.2929～2934.
5Vane JR,Bakhle YS,Botting RM.Cyclooxygenases 1 and 2.Annu Rev Pharmacol Toxicol,1998,38:97～120.
6Kuramochi H,Vallbohmer D,Uchida K,Schneider S,Hamoui N,Shimizu D,Chandrasoma PT,DeMeester TR,Danenberg KD,Danenberg PV,Peters JH.Quantitative,tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.J Gastrointest Surg,2004,8:1007～1017.
7Morris CD,Armstrong GR,Bigley G,Green H,Attwood SE.Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.Am J Gastroenterol,2001,96:990～996.
8Lagorce C,Paraf F,Vidaud D,Couvelard A,Wendum D,Martin A,Flejou JF.Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma.Histopathology,2003,42:457～465.
2MORRIS C D,ARMASTONG G R,BIGLEY G,et al.Cyclooxygenase-2 expression in Barrett's metaplasia-dysplasia-dysplasia-adenocaicinoma sequence[J].Am J Gastroenterol,2001,96:990-996.
3KURAMOCHI H,VALLBOHER D.Quantitative,tissuespific analysis of cyclooxygenase genes expression in the pathogenesis of Barrett's adenocarcinoma[J].GastronintestSurg,2004,8:1007-1017.
4KAUR B S,TRIADAFILOPOULOS G.Acid-and bileinduced PGE(2)release and hyper-proliferation in Barrett s esophagus are COX-2 and PKC-epsilon dependent[J].Am J Physiol Gastrointest Liver Physiol,2002.283:G327-G334.
5BUSKENS C J,VAN REKS B P,SIVULA A,et al.Prognostic significance of elevated cyclooxygenase-2 expression in patients with asenocarcinoma of the esophagus[J].Gastroenterology,2002,122:1800-1807.
6AGGARWAL S,TANEIA N,LIN L,et al.Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involes upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression[J].Neoplasia,2000,2:346-356.
7BUTTER N S,WANG K K,LEONTOVICH O,et al,Chemoprevention of esophageal adenocarcinoma by COX-inhibitors in an animal model of Barretts esophagus[J].Gastrooenterology,2002,122:1172-1175.
8BUSKENS C J,RISTIMAKI A,OFFERHAUS G J,et al.Role of Cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma[J].Scand J Gastronenterol Suppl,2003,239:87-93.
